RICHMOND, BRITISH COLUMBIA--(Marketwire - Oct. 4, 2007) - MEDICAL VENTURES CORP. (TSX VENTURE:MEV) has submitted to the U.S. Food and Drug Administration the second of three modules of its pre-market approval (PMA) application for the Metricath Gemini® catheter. The FDA will review the modules to determine whether the Gemini device will be approved for use in coronary arteries in the United States.
